Startups channel feed – Endpoints News

Startups channel feed

Hunger-suppressing biotech Aardvark raises $94M in IPO

3 months ago

Newleos, a new biotech with $93.5M, repurposes Roche's experimental CNS drugs

3 months ago

After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker

3 months ago

Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing

3 months ago

Less than two years after blockbuster IPO, Acelyrin merges with Alumis to combine cash, assets

3 months ago

With first drug now in the clinic, Alys eyes megaround for rest of pipeline

3 months ago

How opioid addiction treatment startup Bicycle Health reached a profit

3 months ago

Flagship spinout Omega is days away from bankruptcy, filing shows

3 months ago

Sionna seeks $135M IPO to fuel tests of cystic fibrosis drug candidates

3 months ago

Australian biotech AdvanCell nabs $112M Series C for radiopharmaceuticals

3 months ago

Friday IPO doubleheader from Maze and Metsera brings life to biotech debuts

3 months ago

8VC, a tech and life sciences VC firm behind Altos Labs, eyes $1B fund

3 months ago

Atalanta gets $97M boost to take two siRNAs into clinic for rare neuro disorders

3 months ago

Versant's fourth obesity biotech starts with $65M and a GIP antagonist

3 months ago

Obesity startup Found drives weight loss with low-cost generic drugs over GLP-1s, new study shows

3 months ago

Metsera outlines $250M IPO plans as obesity biotech competition rises

3 months ago

Maze looks to lead IPO queue with $113M Nasdaq debut

3 months ago

UK biotech launches with T cell therapy technology to treat solid tumors

3 months ago

With Sam Altman’s help, Retro Biosciences eyes $1B to extend lifespan by 10 years

4 months ago

Obesity biotech Aardvark files for IPO to advance oral, hunger-suppressing drug

4 months ago

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

4 months ago

Sionna and Odyssey end JPM week with IPO filings

4 months ago

Another US biotech emerges with drug candidate from China-based Keymed

4 months ago

Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio

4 months ago

First page Previous page 2 3 456 7 8 Next page Last page